Method & Material: This study was performed on 36 normal-hearing subjects aged 18-25 years for survey of temporary threshold shift (TTS) by transient evoked otoacoustic emissions. Finding: Noise can affect the pure-tone thresholds and (TEOAEs) amplitudes. When cochlea affected by noise, evaluating TEOAE is more suitable than pure-tone audiometry. Because of this test, is objective an unaffected by attention and alertness and can be evaluated in difficult to test subject and also have high carefulness and can be performed in a quiet, but not sound-proof room.

Objective: The purpose of study was identify hearing loss in thalassemic patients with history of Desferrioxamine (DFO) therapy. This study was carried out in a cross-sectional descriptive survey on 195 thalassemic patients (3-30 years old) in Gazvin Thalassemia center and Tehran pediatrics&apos medical center.
Methods: The patients underwent routine otolaryngologic history and physical examination, along with standard pure-tone audiometry.
Results: Hearing loss was present in 43.1% of patients. 16% of patients had conductive hearing loss and 4.6% of patient had sensory neural hearing loss. 22.5% of thalassemic patients had high-frequency sensory neural hearing loss and more importantly, high-frequency hearing loss attributable to Desferrioxamine ototoxicity was present in 12% of patients. Furthermore, these evaluations showed that there is a significant relationship between hearing loss and DFO usage and hearing loss too. There is no significant relationship between hearing loss and ferritin level between hearing loss and age of DFO usage too.
Conclusion: Management of these patients requires proper dosing of Desferrioxamine, along with regular otolaryngolgic and audiometric follow-up in order to prevent the effect of ototoxicity of desferal.

Background and Aim: Diabetes mellitus is a metabolic disorder that affects multiple systems including the auditory and vestibular systems. Patients with diabetes mellitus complain of tinnitus and dizziness. The objective of this study is to assess the effects of diabetes mellitus types I and II on auditory and vestibular systems.

Methods: We compared pure-tone audiometric results and cervical vestibular evoked myogenic potentials ( cVEMPs) between 15 patients with diabetes mellitus type I (43.80 with SD 4.246), 15 patients with diabetes mellitus type II (48.13 with SD 2.973), and 10 normal volunteers (45.30 with SD 4.448). Age range of the participants was 40-50 years old.

Results: Audiometric results showed normal hearing in both types of diabetes mellitus. In contrast, comparing amplitude of cVEMPs between diabetes mellitus and control groups showed statistically significant differences (p<0.05).

Conclusion: In spite of normal audiometric results in patients with diabetes mellitus types I and II, there was abnormal vestibular responses involving vestibular end-organ and related central pathway.